| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2021 | LFCR Lifecore Biomedical, Inc. \de\ | Morberg John D | Chief Financial Officer | Buy | 2,000 | $10.18 | $20,360.00 | +21.3% | +8.2% | -0.8% | |
| Apr 13, 2021 | LQDA Liquidia Corp | Jeffs Roger66 | Director | Buy | 99,206 | $2.52 | $249,999.12 | +793.6% | +3.9% | +105.1% | |
| Apr 13, 2021 | LQDA Liquidia Corp | Manning Paul B54 | Director, 10% Owner | Buy | 198,413 | $2.52 | $500,000.76 | +36.8% | +3.9% | +105.1% | |
| Apr 13, 2021 | PCRX Pacira Biosciences, Inc. | Williams Kristen Marie76 | Chief Administrative Officer | Sell | 21,823 | $66.95 | $1,461,068.50 | -27.8% | -16.8% | +11.1% | |
| Apr 13, 2021 | LFCR Lifecore Biomedical, Inc. \de\ | Wynnefield Partners Small Cap Value LP I65 | 10% Owner | Buy | 240,587 | $10.02 | $2,410,359.59 | +5.2% | +8.2% | -0.8% | |
| Apr 12, 2021 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | President &CEO | Sell | 19,421 | $20.66 | $401,276.70 | -2.7% | +30.3% | +175.6% | |
| Apr 12, 2021 | LFCR Lifecore Biomedical, Inc. \de\ | Burgess Timothy P | Senior VP Of Supply Chain | Buy | 5,045 | $9.99 | $50,399.55 | +98.9% | +11.8% | +3.5% | |
| Apr 12, 2021 | HROW Harrow, Inc. | Harrow Health, Inc. | 10% Owner | Sell | 1,518,000 | $7.00 | $10,626,000.00 | -43.4% | +15.8% | -2.2% | |
| Apr 9, 2021 | LNTH Lantheus Holdings, Inc. | McHugh Julie53 | Director | Sell | 2,800 | $21.22 | $59,416.00 | -10.8% | +33.2% | +186.1% | |
| Apr 9, 2021 | ORGO Organogenesis Holdings Inc. | Wisdom Starr | 10% Owner | Sell | 566,297 | $10.52 | $5,958,963.63 | -23.2% | -27.6% | -65.6% | |
| Apr 8, 2021 | LNTH Lantheus Holdings, Inc. | Leno Sam R | Director | Sell | 5,000 | $21.17 | $105,840.00 | -10.9% | +32.9% | +184.2% | |
| Apr 7, 2021 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 8,155 | $0.67 | $5,502.84 | - | - | - | |
| Apr 1, 2021 | UTHR United Therapeutics Corp | Olian Judy D.60 | Director | Sell | 4,207 | $184.96 | $778,126.72 | -42.1% | -6.7% | -4.0% | |
| Apr 1, 2021 | AKBA Akebia Therapeutics, Inc. | Spellman David A52 | SVP, CFO And Treasurer | Sell | 790 | $3.40 | $2,686.00 | -1.0% | +13.8% | -79.9% | |
| Apr 1, 2021 | AKBA Akebia Therapeutics, Inc. | Dahan Michel59 | SVP, Chief Operating Officer | Sell | 1,211 | $3.40 | $4,117.40 | -0.5% | +13.8% | -79.9% | |
| Apr 1, 2021 | ZTS Zoetis Inc. | Kelly Robert Edward | Executive Vice President | Sell | 2,055 | $158.05 | $324,792.75 | -18.9% | +18.2% | +21.7% | |
| Apr 1, 2021 | DVAX Dynavax Technologies Corp | Novack David F73 | President &COO | Sell | 20,000 | $9.92 | $198,400.00 | -14.6% | +1.2% | +15.7% | |
| Apr 1, 2021 | AKBA Akebia Therapeutics, Inc. | Faulkingham Dell70 | SVP, CCO | Sell | 952 | $3.40 | $3,236.80 | -0.7% | +13.8% | -79.9% | |
| Apr 1, 2021 | AKBA Akebia Therapeutics, Inc. | Hadas Nicole R.60 | SVP, Chief Legal Officer | Sell | 1,060 | $3.40 | $3,604.00 | -0.4% | +13.8% | -79.9% | |
| Apr 1, 2021 | AKBA Akebia Therapeutics, Inc. | Burke Steven Keith61 | SVP, Chief Medical Officer | Sell | 1,081 | $3.40 | $3,675.40 | -0.6% | +13.8% | -79.9% | |
| Apr 1, 2021 | AKBA Akebia Therapeutics, Inc. | Butler John P.61 | CEO And President | Sell | 4,109 | $3.40 | $13,970.60 | -0.4% | +13.8% | -79.9% | |
| Mar 31, 2021 | PCRX Pacira Biosciences, Inc. | Winston Roy68 | Chief Clinical Officer | Sell | 22,224 | $70.61 | $1,569,195.17 | -20.5% | -13.4% | +8.9% | |
| Mar 22, 2021 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 10,822 | $0.90 | $9,747.80 | - | - | - | |
| Mar 22, 2021 | BMY Bristol Myers Squibb Co | Caforio Giovanni59 | Chairman And CEO | Sell | 25,000 | $62.20 | $1,555,000.00 | -4.5% | +6.3% | +15.4% | |
| Mar 19, 2021 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 9,178 | $0.91 | $8,313.96 | - | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.